[1] |
Liu Juxiu, Zhang Jianhua, Wen Junjun, Jiang Xiaoshuang.
Analysis and trend prediction of Mycobacterium tuberculosis drug resistance in Jilin City
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 348-354.
|
[2] |
Ye Zhiteng, Ren Fei, Wang Hua, Yang Ming, Chen Yu, Chen Xiaohong, Wang Yun, Fan Lin.
Treatment outcomes and influencing factors in elderly patients with multidrug/rifampicin-resistant pulmonary tuberculosis: a national multicenter, retrospective cohort study
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1023-1029.
|
[3] |
Liang Yuexin, Liu Aimei, Zeng Huipin, Huang Lihua, Lyu Liuying, Zeng Xinyan, Li Liyuan, Huang Junli.
Strategy-analysis of drug-resistant tuberculosis screening based on all suspected tuberculosis patients of Liuzhou City, Guangxi, 2019—2020
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 958-966.
|
[4] |
Ye Zhiteng, Ren Fei, Wang Hua, Yang Ming, Chen Yu, Chen Xiaohong, Wang Yun, Fan Lin.
Analysis of influencing factors of treatment outcomes of retreated multidrug-resistant/rifampicin-resistant pulmonary tuberculosis patients: a national multicenter retrospective cohort study
[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 778-784.
|
[5] |
Xu Henan, Lai Congjuan, Zhang Zunjing, Guo Jing, Xu Lixia, Zhang Ying, Liu Zhongda.
Analysis of drug resistance in clinical isolates from 610 elderly tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1490-1495.
|
[6] |
Shi Chunjing, Liu Xing, Li Longfen, Li Wenming, Zhang Huajie, Wang Ge, Zeng Haiyan, Liu Li, Shen Lingjun.
Research progress on the effects of bedaquiline,delamanid and pretomanid on liver function in the treatment of multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1560-1565.
|
[7] |
Li Xuelian, Jing Wei, Wang Qingfeng, Chu Naihui, Nie Wenjuan.
An all-oral shortened regimen containing new drugs to treat MDR/rifampicin-resistant tuberculosis: three case reports and literature review
[J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1327-1334.
|
[8] |
Guo Jing, Pang Jialei, Gao Weiwei, Cai Min, Lin Feishen, Zhang Xia.
Phenotypic drug resistance spectrum analysis of adult patients with active pulmonary tuberculosis complicated with diabetes mellitus in Nanjing from 2019 to 2021
[J]. Chinese Journal of Antituberculosis, 2024, 46(1): 62-69.
|
[9] |
Zheng Rui, Zhao Mingrui, Yang Yuanzheng.
Meta-analysis of effectiveness and safety of the cycloserine-containing treatment for multidrug-resistant pulmonary tuberculosis in China
[J]. Chinese Journal of Antituberculosis, 2023, 45(7): 658-668.
|
[10] |
Zhuo Wenji, Zhang Chenchen, Chen Xunxun, Wei Wenjing, Yu Meiling, Peng Kehao, Xu Liuyue, Chen Yanmei.
Analysis of drug resistance characteristics of pulmonary tuberculosis in children in Guangdong, 2014—2020
[J]. Chinese Journal of Antituberculosis, 2023, 45(7): 687-692.
|
[11] |
Lai Min, Wu Guihui, Chen Hongde, Cheng Yao, Luo Haixia, He Kejing.
Clinical characteristics and maternal and infant outcomes of 13 pregnant women with rifampicin resistant and multidrug resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(4): 412-419.
|
[12] |
Zhou Feng, Li Tongxin, Yang Song, Tang Shenjie.
Progress on short-course regimens for the treatment of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(3): 311-317.
|
[13] |
Zhou Yan, Zhou Meng, Peng Jun, Duan Qionghong, Chen Jun, Zhou Meilan, Zhang Yunxia, Liang Jun.
Analysis on transmission of multidrug-resistant pulmonary tuberculosis in family
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 195-199.
|
[14] |
Zhan Jian, You Guoqing, He Xia, Kong Jueying, Liu Wenguo, Feng Xin, Hu Yan.
Investigation of the inconsistent results between two methods in determining fluoroquinolone resistance against Mycobacterium tuberculosis isolates
[J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1058-1063.
|
[15] |
Wang Chaohong, Sun Qing, Liao Xinlei, Yan Jun, Wang Chenqian, Jiang Guanglu, Wang Fen, Xue Yi, Huang Hairong, Wang Guirong.
Analysis of drug resistance situation of Mycobacterium tuberculosis strains from 231 spinal tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 940-946.
|